Deutsch English Français

Contact

EP0270290

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0270290

EP0270290 - Method and compositions for reducing neurotoxic injury [Right-click to bookmark this link]
Status	The application has been withdrawn Status updated on 19.04.2002 Database last updated on 11.09.2024
Most recent event Tooltip	05.10.2005	Change: Appeal number
Applicant(s)	For all designated states THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 350 Cambridge Avenue, Suite 250 Palo Alto California 94306 / US
	[N/P]
Former [1988/23]	For all designated states THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 350 Cambridge Avenue, Suite 250 Palo Alto, California 94306 / US
Inventor(s)	01 / Choi, Dennis W. 739 San Rafael Place Stanford California 94305 / US
	[1988/23]
Representative(s)	Harrison, David Christopher, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB
	[N/P]
Former [1994/28]	Harrison, David Christopher, et al MEWBURN ELLIS York House 23 Kingsway London WC2B 6HP / GB
Former [1988/23]	Harrison, David Christopher MEWBURN ELLIS York House 23 Kingsway London WC2B 6HP / GB
Application number, filing date	87310323.8	23.11.1987
	[1988/23]
Priority number, date	US19860934733	25.11.1986 Original published format: US 934733
	[1988/23]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP0270290
	Date:	08.06.1988
	Language:	EN
	[1988/23]
	Type:	A3 Search report
	No.:	EP0270290
	Date:	03.06.1992
	Language:	EN
	[1992/23]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	16.04.1992
Classification	IPC:	A61K31/415	[1992/23]
	CPC:	A61K31/485 (EP,KR,US); A61P25/00 (EP); A61P25/08 (EP); A61P25/28 (EP); A61P3/08 (EP); A61P9/00 (EP); (+) A61P9/10 (EP) (-)
	Former IPC [1988/23]	A61K31/485
Designated contracting states	AT, BE, CH, DE, ES, FR, GB, GR, IT, LI, LU, NL, SE [1988/23]
Title	German:	Methode und Präparate zur Reduzierung neurotoxischer Schäden	[1988/23]
	English:	Method and compositions for reducing neurotoxic injury	[1988/23]
	French:	Méthode et compositions pour la réduction de blessure neurotoxique	[1988/23]
Examination procedure	25.11.1992	Examination requested [1993/03]
	11.05.1993	Despatch of a communication from the examining division (Time limit: M06)
	28.12.1993	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	24.02.1994	Reply to a communication from the examining division
	03.08.1994	Despatch of a communication from the examining division (Time limit: M06)
	27.12.1994	Reply to a communication from the examining division
	20.09.1995	Date of oral proceedings
	02.04.1996	Despatch of communication that the application is refused, reason: substantive examination {1}
	02.04.1996	Minutes of oral proceedings despatched
	30.07.1998	Application withdrawn by applicant [2002/23]
Appeal following examination	10.06.1996	Appeal received No. T0837/96
	09.08.1996	Statement of grounds filed
	22.05.1998	Invitation to file observations in an appeal (Time limit: M02) [1998/21]
	29.07.1998	Result of appeal procedure: appeal of the applicant withdrawn
Request for further processing for:	24.02.1994	Request for further processing filed
	28.02.1994	Full payment received (date of receipt of payment) Request granted
	23.03.1994	Decision despatched
Fees paid	Renewal fee
	09.11.1989	Renewal fee patent year 03
	20.11.1990	Renewal fee patent year 04
	11.11.1991	Renewal fee patent year 05
	14.10.1992	Renewal fee patent year 06
	08.11.1993	Renewal fee patent year 07
	15.11.1994	Renewal fee patent year 08
	27.11.1995	Renewal fee patent year 09
	29.11.1996	Renewal fee patent year 10
	27.11.1997	Renewal fee patent year 11
	Penalty fee
	Additional fee for renewal fee
	30.11.1998	12 M06 Not yet paid
	30.11.2001	15 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XP]WO8701036 (UNIV NEW YORK [US]);
		[YP]EP0230370 (MERCK SHARP & DOHME [GB])
		[X] - BRAIN RES., vol. 383, nos. 1-2, 24th September 1986, pages 314-318; F.C. TORTELLA et al.: "Dextromethorphan and carbetapentane: centrally acting non-opioid antitussive agents with novel anticonvulsant properties"
		[Y] - BIOCHEM. PHARMACOL., vol. 33, no. 23, 1st December 1984, pages 3829-3832, Pergamon Press Ltd, GB; S.C. BERRY et al.: "Benz(f)isoquinolines as excitatory amino acid antagonists: an indication of their mechanism of action?"
		[Y] - THE LANCET, 20th July 1985, pages 140-143; R. SCHWARCZ: "Exitatory aminoacid antagonists provide a therapeutic approach to neurological disorders"
		[Y] - CLINICAL SCIENCE, vol. 68, 1985, pages 113-122; B. MELDRUM: "Possible therapeutic applications of antagonists of excitatory anino acid neurotransmitters"
		[YD] - EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 111, no. 2, 8th May 1985, pages 185-190, Elsevier Science Publishers B.V.; H. CHURCH et al.: "Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids"
		[Y] - SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 12, no. 1, 1986, page 64; M.P. GOLDBERG et al.: "Hypoxic cortical neuronal injury is blocked by N-methyl-D-aspartate receptor antagonists"
		[YD] - SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 12, no. 1, 1986, pages 381; D.W. CHOI et al.: "Glutamate neurotoxicity in cortical cell culture is attenuated by N-methyl-D-aspartate receptor antagonists"
		[X] - SCIENCE; vol. 215, no. 4528, 1st January 1982, pages 69-71; AAAS; Y. HOSOBUCHI et al.: "Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone"
		[XP] - NEUROSCIENCE LETTERS, vol. 80, 11th September 1987, pages 11-15, Elsevier Scientific Publishers Ireland Ltd; M.P. GOLDBERG et al.: "Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture"
		[T] - CLINICAL NEUROPHARMACOLOGY, vol. 12, no. 4, August 1989, pages 322-330, Raven Press, Ltd, New York, US; F.O. WALKER et al.: "An open label trial of dextromethorphan in Huntington's Disease"
		[T] - ARZNEIM.-FORSCH./DRUG RES., vol. 41(I), no. 3a, 1991, pages 303-309; J. KRIEGLSTEIN et al.: "Pharmakologische Grundlagen der Therapie der zerebralen Ischämie"
		[T] - CHEMICAL ABSTRACTS, vol. 109, no. 7, 15th August 1988, page 64, abstract no. 48319g, Columbus, Ohio, US; G.K. STEINBERG et al.: "Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia" & NEUROSCI. LETT. 1988, 89(2), 193-7
		[T] - CHEMICAL ABSTRACTS, vol. 107, no. 17, 26th October 1987, page 62, abstract no. 147309u, Columbus, Ohio, US; M.P. GOLDBERG et al.: "Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture" & NEUROSCI. LETT. 1987, 80(1), 11-15
		[T] - CHEMICAL ABSTRACTS, vol. 111, no. 21, 20th November 1989, pages 68-69, abstract no. 187420n, Columbus, Ohio, US; G.K. STEINBERG et al.: "Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits"

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p